These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36544210)

  • 1. Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules.
    Dharampal N; Smith K; Harvey A; Paschke R; Rudmik L; Chandarana S
    J Otolaryngol Head Neck Surg; 2022 Dec; 51(1):46. PubMed ID: 36544210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Nishino M; Mateo R; Kilim H; Feldman A; Elliott A; Shen C; Hasselgren PO; Wang H; Hartzband P; Hennessey JV
    Thyroid; 2021 Aug; 31(8):1253-1263. PubMed ID: 33813868
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(2):1-111. PubMed ID: 35591972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology.
    Duick DS; Klopper JP; Diggans JC; Friedman L; Kennedy GC; Lanman RB; McIver B
    Thyroid; 2012 Oct; 22(10):996-1001. PubMed ID: 22873825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
    Li H; Robinson KA; Anton B; Saldanha IJ; Ladenson PW
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1719-26. PubMed ID: 21865367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of reflexive versus selective molecular testing for indeterminate thyroid nodules.
    Hu QL; Schumm MA; Zanocco KA; Yeh MW; Livhits MJ; Wu JX
    Surgery; 2022 Jan; 171(1):147-154. PubMed ID: 34284895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.
    Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW
    JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.
    Balentine CJ; Vanness DJ; Schneider DF
    Surgery; 2018 Jan; 163(1):88-96. PubMed ID: 29128178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National differences in cost analysis of Afirma Genomic sequencing classifier.
    Ronen O; Oichman M
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):717-724. PubMed ID: 33349964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing for Afirma in Thyroid Nodules with High-Risk Indeterminate Cytology (TIR3B): First Italian Experience.
    Andrioli M; Carocci S; Alessandrini S; Amini M; Van Doorne D; Pace D; Lauria A; Raffaelli M; Trimboli P
    Endocr Pathol; 2020 Mar; 31(1):46-51. PubMed ID: 31960284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis.
    Zanocco KA; Wang MM; Yeh MW; Livhits MJ
    World J Surg; 2020 Feb; 44(2):393-401. PubMed ID: 31538250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules.
    Gortakowski M; Feghali K; Osakwe I
    Thyroid; 2021 Sep; 31(9):1376-1382. PubMed ID: 33764195
    [No Abstract]   [Full Text] [Related]  

  • 16. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroseq v3, Afirma GSC, and microRNA Panels Versus Previous Molecular Tests in the Preoperative Diagnosis of Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.
    Silaghi CA; Lozovanu V; Georgescu CE; Georgescu RD; Susman S; Năsui BA; Dobrean A; Silaghi H
    Front Endocrinol (Lausanne); 2021; 12():649522. PubMed ID: 34054725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ThyroSeq
    Rivas AM; Nassar A; Zhang J; Casler JD; Chindris AM; Smallridge R; Bernet V
    Endocr Pract; 2018 Sep; 24(9):780-788. PubMed ID: 30084677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.